RE:RE:$10 mil cash left, Breakeven EPS/FCF, 2% organic or nilWhy are you conveniently leaving out the effects of organic growth? Backlogs are coming down, they are acquiring more inventory, expanding into new territories, and entering interesting new insurance contracts. It doesn't all need to be done through pure acquisitions. Also, they have now turned the corner on operational profitability so new funding is coming through future operations, and there is still the line of credit possibility. If the debentures get taken out in 2022 this is an added bonus. They will meet their targets and the share price will inevitably continue to climb.